BRENDA REILLY: Open Payments
NPI 1255772471 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 108 payments from 14 companies in 2025. Trend: 2023 $2,190 · 2024 $1,855 · 2025 $2,262
Food & beverage: $2,190Education: $72
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $369 |
| Vanda Pharmaceuticals Inc. | 9 | $270 |
| Teva Pharmaceuticals USA, Inc. | 14 | $249 |
| Lundbeck LLC | 11 | $234 |
| Alkermes, Inc. | 10 | $196 |
| HARMONY BIOSCIENCES LLC | 5 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $190 |
| Neurocrine BioSciences, Inc. | 7 | $186 |
| E.R. Squibb & Sons, L.L.C. | 12 | $182 |
| ABBVIE INC. | 4 | $88 |
Products named: REXULTI, ABILIFY ASIMTUFII, HETLIOZ, CAPLYTA, INGREZZA, COBENFY, ARISTADA, UZEDY.
Industry payments across IL — which companies pay providers there.
